Vantro
Health
Market Brief
Platform
Compare Markets
Side-by-side comparison across 2-6 markets.
Top 5 Markets
Rank the best-fit markets for your product by regulatory, procurement, and access score.
Global Value Dossier
HTA pathways, pricing corridors, and evidence requirements by market.
Pricing & Evidence Simulator
Model conservative, base, and optimistic reimbursement outcomes across markets.
Scenario Planner
PESTLE risk scan and named scenarios: plan now or monitor.
Regulatory Tracker
Monitor regulatory and market changes across your target markets, alerts at your chosen frequency.
Match
Enterprise
Pricing
Book a call
Get Started
Market Brief
Platform
โพ
Compare Markets
Side-by-side comparison across 2-6 markets.
Top 5 Markets
Rank the best-fit markets for your product by score.
Global Value Dossier
HTA pathways, pricing corridors, and evidence requirements by market.
Pricing & Evidence Simulator
Model conservative, base, and optimistic reimbursement outcomes across markets.
Scenario Planner
PESTLE risk scan and named scenarios: plan now or monitor.
Regulatory Tracker
Monitor regulatory and market changes across your target markets, alerts at your chosen frequency.
Match
Enterprise
Pricing
Book a call
Get Started
Market Analysis
Compare Markets
Enter your product profile to see ranked market recommendations and entry sequencing.
Product Type *
Select product type...
Timeline Constraint *
Select timeline...
Under 12 months
12-18 months
18+ months
Flexible
Existing Regulatory Clearances
CE Mark
FDA 510(k)
WHO Prequalification
TGA Australia
Health Canada
EU MDR
IVDR
PMDA Japan
NMPA China
ANVISA Brazil
None yet
Market Type *
๐ Global
๐บ๐ธ US States
Select 2 to 6 countries to compare
Sub-Saharan Africa
๐จ๐ฒ
Cameroon
๐จ๐ฎ
Cรดte d'Ivoire
๐จ๐ฉ
DRC
๐ช๐น
Ethiopia
๐ฌ๐ญ
Ghana
๐ฐ๐ช
Kenya
๐ฒ๐ฟ
Mozambique
๐ณ๐ฌ
Nigeria
๐ท๐ผ
Rwanda
๐ธ๐ณ
Senegal
๐ฟ๐ฆ
South Africa
๐น๐ฟ
Tanzania
๐บ๐ฌ
Uganda
๐ฟ๐ฒ
Zambia
๐ฟ๐ผ
Zimbabwe
MENA
๐ช๐ฌ
Egypt
๐ฎ๐ถ
Iraq
๐ฏ๐ด
Jordan
๐ฐ๐ผ
Kuwait
๐ฑ๐ง
Lebanon
๐ฒ๐ฆ
Morocco
๐ถ๐ฆ
Qatar
๐ธ๐ฆ
Saudi Arabia
๐น๐ณ
Tunisia
๐ฆ๐ช
UAE
South Asia
๐ง๐ฉ
Bangladesh
๐ฎ๐ณ
India
๐ณ๐ต
Nepal
๐ต๐ฐ
Pakistan
๐ฑ๐ฐ
Sri Lanka
Southeast Asia
Cambodia
๐ฎ๐ฉ
Indonesia
๐ฒ๐พ
Malaysia
๐ฒ๐ฒ
Myanmar
๐ต๐ญ
Philippines
๐ธ๐ฌ
Singapore
๐น๐ญ
Thailand
๐ป๐ณ
Vietnam
East Asia
๐จ๐ณ
China
๐ฏ๐ต
Japan
๐ฐ๐ท
South Korea
๐น๐ผ
Taiwan
Central Asia & Caucasus
๐ฌ๐ช
Georgia
๐ฐ๐ฟ
Kazakhstan
Latin America
๐ฆ๐ท
Argentina
๐ง๐ท
Brazil
๐จ๐ฑ
Chile
๐จ๐ด
Colombia
๐ฒ๐ฝ
Mexico
๐ต๐ฆ
Panama
๐ต๐ช
Peru
Europe
๐จ๐ฆ
Canada
๐ซ๐ท
France
๐ฉ๐ช
Germany
๐น๐ท
Turkey
๐ฌ๐ง
UK
๐บ๐ฆ
Ukraine
Oceania
๐ฆ๐บ
Australia
๐ณ๐ฟ
New Zealand
Priority *
Speed to market
Prioritise markets with shortest path to approval
Volume potential
Prioritise markets by population and disease burden
Donor-funded channel
Prioritise markets with active UNICEF / Gavi / Global Fund procurement
Private sector revenue
Prioritise markets with strong private sector and pricing flexibility
Compare markets โ